EGElif Güler

Elif Güler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elif Güler has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sleep Patterns Across the Transfusion Cycle in Children with Transfusion-Dependent β-Thalassemia: A 14-Day Prospective Controlled Study Using Sleep Diaries and Repeated Questionnaires

    by Senay Türe, Funda Tayfun Küpesiz, Zeynep Ozturk, Alphan Kupesiz, Elif Guler, Sevtap Velipasaoglu

    Background/Objectives: Sleep across the transfusion cycle remains understudied in children with transfusion-dependent β-thalassemia (TDT). We assessed sleep patterns and hematologic correlates before and after transfusion. Methods: This prospective, controlled, repeated-measures study included 27 children with TDT and 30 controls who had been frequency-matched at recruitment on age, sex, and school-attendance category; no fixed one-to-one patient–control pairs were formed. Participants completed 14-day sleep diaries spanning the pre- and post-transfusion weeks and repeated Children’s Sleep Habits Questionnaire (CSHQ) and Pittsburgh Sleep Quality Index (PSQI) assessments. The three primary outcome domains were sleep-diary measures (including sleep regularity, daytime nap frequency, sleep-duration variability, and nocturnal awakenings), continuous CSHQ total and subscale scores, and the continuous modified PSQI global score. Threshold classifications, individual questionnaire items, and laboratory/MRI associations were exploratory. Multiplicity was controlled within the diary and questionnaire families using the Benjamini–Hochberg false discovery rate (FDR). Results: Within the primary sleep-diary domain, weekday sleep irregularity was greater in patients pre-transfusion (16.3 vs. 10.2 min; q = 0.014) but not post-transfusion (q = 0.220); sleep-duration variability was greater before and after transfusion (both q = 0.026), and diaries recorded more daytime naps and more and longer nocturnal awakenings across 14 days (q < 0.05). Within the primary questionnaire domains, the continuous modified PSQI global score and CSHQ total, sleep-behavior, and daytime-sleepiness scores were higher in patients pre-transfusion (all q < 0.001). In exploratory, unadjusted analyses, lower pre-transfusion hemoglobin correlated with greater daytime sleepiness (ρ = −0.425; p = 0.027). Conclusions: Multiplicity-adjusted findings across the three primary outcome domains suggest differences in reported sleep timing, regularity, continuity, daytime napping, and questionnaire scores in children with TDT. However, the small sample, the number of component outcomes and contrasts, and the absence of actigraphy require cautious interpretation.

  • Evaluation of Post-Traumatic Stress Disorder and Perception of Loneliness in Children Who Underwent Hematopoietic Stem Cell Transplantation

    by Zehra İşLeyen Bodur, Arif Önder, Hilal Yazici Kopuz, Asli Sürer Adanir, Özge Gizli Çoban, Berhan Akdağ, Ezgi Mutlu Akar, Funda Tayfun Küpesiz, Elif Güler, Alphan Küpesiz

    Background: Hematopoietic stem cell transplantation (HSCT) is associated with post-traumatic stress disorder (PTSD), depression, and anxiety in pediatric survivors, but studies on loneliness in these patients remain limited. Aim: This study aims to explore how PTSD relates to perceptions of loneliness, depression, and anxiety disorders among pediatric HSCT survivors. Methods: This cross-sectional study included 60 patients who underwent HSCT, 60 patients with various hematological/oncological conditions who did not undergo HSCT, and 65 controls. The Child Post-Traumatic Stress Reaction Index, the UCLA Loneliness Scale, and the Revised Children’s Anxiety and Depression Scale were used to assess PTSD, perceptions of loneliness, and depression and anxiety disorders, respectively. Results: Both HSCT (+) and HSCT (−) groups demonstrated significantly higher PTSD, depression, and anxiety scores compared with the control group. Perceived loneliness was significantly higher in the HSCT (+) group compared with the HSCT (−) and control groups. In addition, a significant positive correlation was observed between PTSD scores and loneliness scores in HSCT (+) and HSCT (−) groups. Conclusion: Staying in an isolation room during HSCT may be a contributing factor to loneliness and PTSD in pediatric survivors. Early recognition and treatment of PTSD symptoms and addressing loneliness are crucial for effective care during and after HSCT.

  • Open Access

    Hemoglobin D and Coinheritance with Hb S, β-thalassemia

    by Zeynep Öztürk, Osman Alphan Küpesiz, Elif Güler, Funda Tayfun Küpesiz

    Objective: Hb D-Punjab (also known as D-Los Angeles) is a recessively inherited variant of hemoglobin. It is one of the most common hemoglobin variants worldwide. In this study, we aimed to evaluate the hematological features of our homozygous and heterozygous Hb D patients and patients with compound heterozygosity for Hb D and other hemoglobinopathies in terms of clinical and laboratory findings. Methods: In this study, cases with Hb D-Punjab have been identified in both the heterozygous and homozygous states, as well as coinheritance with Hb S or β-thalassemia. We presented the clinical and laboratory characteristics of 18 cases (Hb D/D (n=2), Hb D/β-thalassemia (n=3), and Hb S/D (n=3) and Hb D traits (n=10)). Results: As a result of the study, it was observed that Hb D was asymptomatic in both heterozygous and homozygous forms. Hb D/β thalassemia cases showed mild microcytic and hypochromic anemia, but they were clinically normal. Compound heterozygosity for Hb S/D showed moderate hemolytic anemia, but a severe clinical picture with painful crises, just like sickle cell patients. Conclusion: Hemoglobin D-Punjab, which is asymptomatic even in homozygous conditions, can cause a variety of clinical pictures from mild to severe when inherited in combination with other hemoglobinopathies.

  • Open Access

    Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience

    by Funda Tayfun Küpesiz, Ayşe Nur Akınel, Hilal Akbaş, Çiğdem Sivrice, Gülen Tüysüz Kintrup, Güngör Karagüzel, Mustafa Melikoğlu, Mustafa Tekinalp Gelen, Bülent Aydınlı, Alphan Küpesiz, et al.

    Background: Hepatoblastoma is rare cancer that responds well to risk-based chemotherapy, and surgical treatment is needed to achieve complete remission and satisfactory survival rates in hepatoblastoma patients. In this study, we evaluated the clinical features and treatment outcomes of pediatric hepatoblastoma patients treated in our clinic. Methods: Eighteen patients with hepatoblastoma who were treated and followed up in our center between June 1999 and June 2020 were analyzed retrospectively. All patients were evaluated by a multidisciplinary team and managed using a risk-based protocol (SIOPEL-1 and SIOPEL-3). Results: The patients’ mean age at diagnosis was 38.33 ± 52.34 months. Sixteen patients (89%) received neoadjuvant chemotherapy, and 2 patients (11%) who underwent complete mass excision at diagnosis received adjuvant chemotherapy. After neoadjuvant therapy, the tumor was completely resected in 8 patients (45%), while liver transplantation was performed in 6 patients (34%) because complete resection of the tumor was not possible. Two patients died before surgical treatment. One patient relapsed with lung metastasis after salvage chemotherapy. She is alive without disease at 64 months. The mean follow-up time was 59.3 ± 49.8 months; 5-year overall and disease-free survival rates were 88.9% and 80.8%, respectively. The 5-year overall survival rate was 100% for both liver transplant and resected patients, whereas 5-year disease-free survival was lower in transplant patients (75% vs 100%, P < .001). Conclusion: Multidisciplinary follow-up is especially important for patients who may need liver transplantation. Some patients may benefit from new treatment options such as radiofrequency ablation and cyberknife treatment. Cite this article as: Tayfun Küpesiz F, Akınel AN, Akbaş H, et al. Multidisciplinary management of pediatric hepatoblastoma: A 20-year single-center experience. Turk J Gastroenterol. 2022;33(12):1069-1078.


  • The effect of a peer‐assisted video‐based training programme and counselling to reduce anxiety in children newly diagnosed with cancer: Non‐randomised controlled trial

    by Münevver Erkul, Emine Efe, Elif Güler

    Objective The aim of this study is to evaluate the effect of 'peer-assisted video-based education programme' (VTPA) and counselling to reduce anxiety in children newly diagnosed with cancer. Methods A non-randomised controlled trial design with repeated measures was conducted. The sample of the study consisted of 50 children between the ages of 9 and 18 who were newly diagnosed with cancer in the hospital. Intervention and control groups were created. Children in the intervention group received both VTPA training and counselling practice 3 days a week for 2 months. Data were collected with the State-Trait Anxiety Inventory for Children. The basal assessment in the research was the first meeting with the child, with interval assessments 1 month after, 2 months after and 3 months after the education. Results In the study, it was determined that the state anxiety mean scores of the children in the PAVEP and control groups differed over time (p < 0.05). However, it was determined that there was no difference between the trait anxiety mean scores of the children (p > 0.05). Conclusion VTPA with peer assistance and counselling application supported the reduction of state anxiety in children newly diagnosed with cancer over time.


  • Can peripheral blood monocyte percentage and lymphocyte monocyte ratio at diagnosis predict survival in pediatric neuroblastoma patients?

    by Koray Yalçın, Gülen Tüysüz, Funda Tayfun Küpesiz, Selen Bozkurt, Alphan Küpesiz, Elif Güler

    Background. Previous studies have shown that the immune system plays a critical role in cancer pathogenesis. The lymphocyte monocyte ratio (LMR) and monocyte percentage (MP) have been found to be prognostic factors in various types of adult cancers. But studies about pediatric tumors are scarce and to our knowledge, there are no studies evaluating the immune system effect in pediatric neuroblastoma patients. The aim of this study was to assess whether LMR and MP at diagnosis may have an effect on prognosis in neuroblastoma patients. Methods. We retrospectively analyzed MP and LMR at diagnosis in 71 pediatric neuroblastoma patients treated between 2002 and 2016. Results. The optimal cut-off values of LMR and MP were determined using the receiver operating characteristics curves (ROC) and area under the curve (AUC). We found that a low LMR (≤3.5) and a high MP (≥7.5%) were correlated with worse overall survival and shorter event-free survival in univariate analysis. Multivariate analysis revealed that elevated LMR was an independent factor for better OS and EFS. Conclusions. In conclusion, LMR and MP might be valuable prognostic factors for predicting OS in neuroblastoma patients. Multicenter and prospective studies are warranted to confirm this hypothesis.


  • Open Access

    Clinical Characteristics and Treatment Outcomes of Patients with Malignant Extracranial Germ Cell Tumors: A 20-Year Single-Center Experience

    by Funda Tayfun Küpesiz, Gülen Tüysüz, Ayşe Nur Akınel, Ayşegül Tekneci, Ayşe Çiğdem Sivrice, Mustafa Melikoglu, Hadice Elif Pestereli, Osman Alphan Küpesiz, Elif Güler


  • Open Access

    Cross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives

    by Sonay İnCesoy Özdemi̇r, Nurdan Taçyildiz, Ali Varan, Rejin Kebudi̇, Bülent Zülfi̇kAr, Tiraje Celkan, Gürses Şahi̇n, Funda Çorapçioğlu, Zuhal Keski̇n Yi̇lDi̇rİm, Faruk Güçlü Pinarli, et al.

    The main purpose of this study is to determine; the current status of long term follow up (LTFU) for childhood cancer survivors and the challenges of LTFU for pediatric cancer survivors at pediatric oncology institutions in Turkey. An e-mailed questionnaire has been sent to directors of 33 pediatric oncology centers registered in the Turkish Pediatric Oncology Group (TPOG).Twenty one of 33 active institutions of the TPOG participated in the study and returned their completed questionnaires. Only 1 of the 21 participating centers had a separate LTFU clinic. The remaining centers had provided LTFU care for chilhood cancer survivors at the pediatric oncology outpatient clinic. Seventeen (80.9%) centers reported difficulty transition from pediatric clinic to adult clinic, 14 centers (66.6%) reported insufficient care providers, 12 (57.1%) centers reported insufficient time and transportation problems. As neglected late effects; 16 (76.1%) centers reported psychosocial and getty job problems, 11 (52.3%) centers reported sexual and cognitive problems. None of the centers have their own LTFU guideline for their daily LTFU practice. This study is the first to gain an overview of the needs of pediatric oncology centers and the gaps in survivorship services in Turkey. The results from this study will help develope a national health care system and national guideline for pediatric cancer survivors.


  • Open Access

    Pediatric tonsillar synovial sarcoma- very rare localization: a case report and review of the literature

    by Koray Yalcin, Gulen Tuysuz, Mine Genc, Irem Hicran Ozbudak, Alper Tunga Derin, Kamil Karaali, Alphan Kupesiz, Elif Guler

    Tonsillar synovial sarcoma is an extremely rare entity and only 9 adult patients have been reported up to now. Here, we describe the first pediatric tonsillar synovial sarcoma of the literature in a patient who presented with a 2-month history of dysphagia and snoring. Clinical and radiological examinations showed that the tumor arose from the right palatine tonsil and narrowed the parapharyngeal space. An incisional biopsy from the palatine tonsil revealed the diagnosis of synovial sarcoma. The patient has underwent total tonsillectomy and received radiotherapy and chemotherapy because of the positive surgical margins. The patient is clinically in good condition and free of tumor 30 months after the initial diagnosis. We achieved a long-term complete remission with a combination of surgery, radiotherapy and chemotherapy in our case. Tonsillar synovial sarcoma should be kept in mind while dealing with tonsillar masses. We can conclude that a multidisciplinary approach is warranted while treating synovial sarcoma with this localization.